TP53 and inflammatory breast carcinoma: While few studies have evaluated specific DNA repair pathways, our findings that IBC has more p53 mutations (64% for IBC vs. 46% for non-IBC) concurs with previously published findings (57% to 75% of IBC cases had TP53 mutation) [52–55].